Embecta Corp. (EMBC)
Nasdaq: EMBC · Surgical & Medical Instruments & Apparatus · Wilmington, DE · filing with the SEC since 2021
Who owns Embecta Corp.
As filed with the SECHolders of 5% or more
3
Blackrock, Inc. holds 7.7% of Common Stock, as its SCHEDULE 13G/A filed Jul 8, 2026 says.
Directors and officers
12
report now, of 19 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 8, 2026 · Common Stock · 15% in Jul 18, 2025
Yacktman Asset Management LP
SCHEDULE 13G · filed May 5, 2026 · Common Stock
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Deerfield Mgmt, L.P.
SCHEDULE 13G/A · filed May 13, 2025 · Common Stock · reported falling below 5%
American Century Investment Management, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock · reported falling below 5%, from 5.8% in May 1, 2026
River Road Asset Management, LLC
SCHEDULE 13G/A · filed May 27, 2026 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 7.79% in Jan 30, 2026
What EMBC reports owning in othersstakes of 5% or more, and other ties
55 subsidiaries in 45 countries, from the list filed with the 10-K filed Nov 25, 2025.
Insider tradesForm 4
1sales
4purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$600,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 20 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Kurdikar Devdatt | President and CEO | 0 | $0 | 0 | 1 | $100,000 |
| Elguicze Jacob | SVP and CFO | 0 | $0 | 0 | 1 | $100,000 |
| Mann Jeffrey Z | Pres, Pharm Svc&Prod Mgmt, CLO | 0 | $0 | 0 | 1 | $100,000 |
| Hombach Robert J. | director | 0 | $0 | 0 | 1 | $200,000 |
| Morris Milton Mayo | director | 1 | $0 | 0 | 0 | $0 |